Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | PPM1B | O75688 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14276054 | 0.90 | TSHR (0.39) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL14199490 | 0.90 | TSHR (0.31) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL28121230 | 0.89 | ALDH1A1 (0.42) | TSHRALDH1A1 | |
| SCHEMBL28172002 | 0.89 | ALDH1A1 (0.36) | TSHRALDH1A1TP53HIF1ACYP3A4 | |
| SCHEMBL29942249 | 0.88 | — | — | |
| SCHEMBL14156828 | 0.87 | PPM1B (0.33) | TSHRALDH1A1TP53SMN1; SMN2PPM1B | |
| SCHEMBL9853613 | 0.87 | PPM1B (0.33) | TSHRALDH1A1TP53SMN1; SMN2PPM1B | |
| SCHEMBL9853615 | 0.87 | PPM1B (0.33) | TSHRALDH1A1TP53SMN1; SMN2PPM1B | |
| SCHEMBL1053710 | 0.86 | ALDH1A1 (0.37) | ALDH1A1 | |
| SCHEMBL17281229 | 0.86 | TSHR (0.47) | TSHRALDH1A1TP53HIF1ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1856 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122085593-A | Negative photosensitive composition and use thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-12623006-B2 | Medical instrument | TERUMO KABUSHIKI KAISHA (JP) | 2026-05-12 | — | — | US | claimed |
| US-12545818-B2 | Snap-cure flexible electrically conductive one component (1K) epoxy adhesive composition | HENKEL AG & CO. KGAA (DE) | 2026-02-10 | — | — | US | claimed |
| EP-3919093-B1 | MEDICAL INSTRUMENT MANUFACTURING METHOD AND MEDICAL INSTRUMENT | TERUMO CORP (JP) | 2025-11-19 | — | — | EP | claimed |
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | PIOCEL CO., LTD. (KR) | 2025-07-15 | — | — | US | claimed |
| CN-118852521-B | Fluorine-containing resin for manufacturing pixel Bank layer, synthesis process of fluorine-containing resin and fluorine-containing resin composition | 江苏博砚电子科技股份有限公司 | 2025-06-24 | — | — | CN | claimed |
| WO-2025121279-A1 | MEDICAL INSTRUMENT AND MEDICAL INSTRUMENT MANUFACTURING METHOD | テルモ株式会社 | 2025-06-12 | — | — | WO | claimed |
| CN-116284683-B | Oxygen heterocyclic end-capped resin and adhesive using same | 东莞澳中新材料科技股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| WO-2025089272-A1 | LIGHT CONTROL SHEET, LIGHT CONTROL DEVICE AND METHOD FOR PRODUCING LIGHT CONTROL SHEET | ＴＯＰＰＡＮホールディングス株式会社 | 2025-05-01 | — | — | WO | claimed |
| US-12275822-B2 | Foam, composite material, and foaming composition | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2025-04-15 | — | — | US | claimed |
| WO-2002055620-A2 | POWDERED THERMOSETTING COMPOSITION FOR COATINGS | UCB, S.A. (BE) | 2002-07-18 | — | — | WO | claimed |
| WO-2002050201-A1 | POWDERED THERMOSETTING COMPOSITION FOR COATINGS | UCB, S.A. (BE) | 2002-06-27 | — | — | WO | claimed |
| EP-1027190-A1 | COATED ABRASIVE PRODUCTS | UCB, S.A. (BE) | 2000-08-16 | — | — | EP | claimed |
| US-5922633-A | THERMAL LATENT ACID CATALYST CONSISTS OF AN EPOXY COMPOUND, A SULFUR COMPOUND AND LEWIS ACID | NOF CORPORATION (JP) | 1999-07-13 | — | — | US | claimed |
| WO-1998032566-A1 | COATED ABRASIVE PRODUCTS | UCB, S.A. (BE) | 1998-07-30 | — | — | WO | claimed |
| EP-0422647-B1 | Dispersion of fine particles of a polymer | KANSAI PAINT CO LTD (JP) | 1994-12-28 | — | — | EP | claimed |
| EP-0388858-B1 | HEAT-CURABLE RESINOUS COATING COMPOSITION | KANSAI PAINT CO., LTD. (JP) | 1993-06-16 | — | — | EP | claimed |
| US-5025060-A | Gelled, crosslinked copolymerized poly(12-hydroxystearic acid) and ethylenically unsaturated monomers | KANSAI PAINT CO., LTD. (JP) | 1991-06-18 | — | — | US | claimed |
| EP-0422647-A2 | Dispersion of fine particles of a polymer | KANSAI PAINT CO., LTD. (JP) | 1991-04-17 | — | — | EP | claimed |
| EP-0388858-A1 | Heat-curable resinous coating composition | KANSAI PAINT CO., LTD. (JP) | 1990-09-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12358933-B2 | Meta-POSS (meta-polyhedral oligomeric silsesquioxane) compound, a preparation method thereof, and a composition containing the meta-POSS compound prepared by the preparation method | SPEN, SAE1, OSTC | TSHR 3556/4885ALDH1A1 4639/4885TP53 1196/4885 |
| US-12623006-B2 | Medical instrument | MMAB, MIF, CD44 | TSHR 495/4885ALDH1A1 1547/4885TP53 2575/4885 |
| US-12545818-B2 | Snap-cure flexible electrically conductive one component (1K) epoxy adhesive composition | GJA1, GJB2, CNTN1 | TSHR 3861/4885ALDH1A1 654/4885TP53 4877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.